To Assess the Anti-anginal Safety and Efficacy of Ivabradine in Subjects With Stable，Symptomatic Chronic Angina

NCT02623569 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

336

Enrollment

OTHER

Sponsor class

Conditions

Angina Pectoris

Interventions

DRUG: Ivabradine
DRUG: Atenolol

Sponsor

Xintong Pharmacy Company